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The debate endures as to whether schizophrenia and bipolar
disorder are separate entities or different manifestations of
a single underlying pathological process. Here, we argue
that this sterile argument obscures the fact that the truth
lies somewhere in between. Thus, recent studies support
a model whereby, on a background of some shared genetic
liability for both disorders, patients with schizophrenia
have been subject to additional genetic and/or environmen-
tal factors that impair neurodevelopment; for example,
copy number variants and obstetric complications are as-
sociated with schizophrenia but not with bipolar disorder.
As a result, children destined to develop schizophrenia show
an excess of neuromotor delays and cognitive difficulties
while those who later develop bipolar disorder perform
at least as well as the general population. In keeping
with this model, cognitive impairments and brain structural
abnormalities are present at first onset of schizophrenia but
not in the early stages of bipolar disorder. However, with
repeated episodes of illness, cognitive and brain structural
abnormalities accumulate in both schizophrenia and bipo-
lar disorder, thus clouding the picture.
Keywords: schizophrenia/bipolardisorder/environmental
factors/neurodevelopment
More than a century after Kraepelin’s distinction be-
tween dementia praecox (schizophrenia) and manic de-
pression (bipolar disorder), the major classification
systems continue to categorize them separately. How-
ever, clinicians frequently encounter patients who do
not fall neatly into either category. Furthermore, antipsy-
chotic drugs, once thought only to be useful in schizo-
phrenia, are also effective in bipolar disorder, which is
not surprising given that dopamine dysregulation is im-
plicated in both disorders. Conversely, mood stabilizers
are useful in treating certain schizophrenic patients, and
similarly, antidepressants have a role in treatment of neg-
ative symptoms in schizophrenia.
In this article, we will argue that recent studies support
a model 1,2 whereby, on a background of some shared
genetic liability for both disorders, patients with schizo-
phrenia have been subject to additional genetic and en-
vironmental risk factors that impair neurodevelopment.
Changing Genetic Perspectives
Over the last decade, the traditional view that schizophre-
nia and bipolar disorder are genetically distinct has been
undermined. Thus, applying a nonhierarchical approach
to diagnosis in Maudsley twin series, Cardno et al3
showed that 8.2% of the monozygotic (MZ) co-twins
of probands with Research Diagnostic Criteria schizo-
phrenia had met criteria for mania (8.2%), while 13.6%
of the MZ co-twins of manic probands had met criteria
for schizophrenia.
Family studies have also suggested genetic overlap be-
tween schizophrenia and bipolar disorder. Mortensen
et al4 demonstrated that the risk of bipolar disorder
was increased in those individuals whose parents or sib-
lings had schizophrenia. Furthermore, a large Swedish
family study showed increased risk for both schizophre-
nia and bipolar disorder in first-degree relatives of
patients with either disorder.5 These findings were con-
firmed in a meta-analysis of family studies by van Snel-
lenberg and Candia6 and by Dean et al7 who reported
that individuals with a parental history of nonaffective
psychosis have an increased risk of bipolar disorder
and those with parental affective psychosis have an in-
creased risk of schizophrenia. Thus, the coaggregation
of the 2 disorders in MZ twin pairs and families defies
the notion of distinct genetic disorders.
Genome-wide association studies (GWAS) indicate
that a large number of genes exerting small individual
effects are involved in the transmission of schizophrenia
and bipolar disorder, and although there are inconsisten-
cies, some genes have been implicated in both disorders.
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The International Schizophrenia Consortium8 which
identified the most promising risk alleles from a large
GWAS of schizophrenia, showed that these were found
with excess frequency in bipolar disorder. Other studies
comparing schizophrenia and bipolar GWAS datasets
have demonstrated an overlap in susceptibility genes
across both disorders.
The above might be taken to imply that the genetic
contribution to schizophrenia and bipolar disorder is
largely in common. However, the most recent genetic ev-
idence suggests that there may yet be some life in the
Kraepelinian distinction. Copy number variants
(CNVs) are found in excess in schizophrenia and some
appear to be in common between schizophrenia, autism,
ADHD, and epilepsy. By contrast, CNVs are not found
in excess in bipolar disorder.
Epidemiological and Environmental Similarites and
Differences
Both schizophrenia and bipolar disorder have a typical on-
set between adolescence and mid twenties. Males become
ill earlier than females by around 2.5 years in schizophre-
nia; a similar gender difference is also present for the first
episode ofmania. Amale excess has often been reported in
schizophrenia while most studies of bipolar patients have
reported no sex difference in incidence.
The families of bipolar patients tend to be of a higher
socioeconomic status than the general population, although
we suspect that this finding may be confounded by general
intelligence. Some studies have found an association be-
tween social deprivation at birth and schizophrenia.
One of the environmental factors that differentiate best
between the disorders is urban upbringing, which has
strongly been associated with the risk of schizophrenia,
but not bipolar disorder.9 Further, studies focusing on
the effect of neighborhood variation in city areas have dem-
onstrated much more variation in rates of schizophrenia.
Migrants are at increased risk for schizophrenia. A
meta-analysis estimated the risk for bipolar disorder in
migrants also to be increased10 but this conclusion was
based on only 5 studies, and the excess was attributable
to African Caribbean migrants to the United Kingdom.
When the contribution of the latter group was removed,
the risk of bipolar disorder was no longer significantly in-
creased in migrants. Subsequent individual studies includ-
ing those from our group have reported increased rates of
bipolar disorder among black and other minority ethnic
groups, however, risk remains stronger for schizophrenia.
Obstetric events have been frequently reported to in-
crease risk of schizophrenia; such factors do not seem
to predispose to bipolar disorder. An excess of winter/
spring births has consistently been reported in schizo-
phrenia.While studies have observed associations of win-
ter birth with bipolar disorder, most have not replicated
this.
Recently, rekindled interest in the effects of early child-
hood trauma on developing psychosis led to observations
that child abuse is highly prevalent in both. Particularly,
strong association was observed between childhood
trauma and auditory hallucinations in both disorders.
Both disorders are associated with cigarette and illicit
drug use, particularly cannabis use, but the evidence is
much stronger for schizophrenia. Furthermore, canna-
bis use is associated with earlier age of onset in both
disorders.
Advanced parental age at conception is commoner
than expected in schizophrenia. The fact that autism
is also associated with increased paternal age and that
both it and schizophrenia show an excess of CNVs
has raised the possibility that such mutations may arise
during the repeated mitosis in the progenitor sperm cells
as men age. However, contrary to this, new evidence
suggests that this may be an effect of older age at mar-
riage rather than older age of having children, which can
not be explained by de novo mutations in paternal germ
cells (see Petersen et al11). Research concerning the re-
lationship between paternal age and the risk of bipolar
disorder is sparse.
Finally, individuals with schizophrenia have drasti-
cally reduced reproductive output. Bipolar disorder,
however, is associated with normal reproductive success.
Neuroanatomical Commonalities and Specificities
Patients With Established Illness
People with established schizophrenia show brain struc-
tural abnormalities. Hallahan et al12 performed a collab-
orative mega-analysis of studies of bipolar disorder
analyzing the individual volumetric ratings from 321
patients with bipolar disorder and 442 healthy subjects;
the patients had increased right lateral ventricle volume,
confirming previous findings. But this was to a lesser ex-
tent than in schizophrenia and the laterality difference
was opposite to that in schizophrenia, where ventriculo-
megaly is bilateral but more prominent on the left.
Schizophrenia is additionally associated with extensive
gray matter reductions. In bipolar disorder, generalized
gray matter reductions have not been consistently
reported. The hippocampus and amygdala are reduced
in those with established schizophrenia. Adult patients
with bipolar disorder do not show decrements in the vol-
ume of the hippocampus. Reports regarding amygdala
volume in bipolar disorder have been inconsistent, but
a recent meta-analysis found no change.13
Brain structural abnormalities are more severe in
chronic than first episode schizophrenia. In their mega-
analysis, Hallahan et al12 reported that cerebral volume
was reduced significantly with increasing illness duration.
Other studies also demonstrated reduced total gray mat-
ter volume with illness duration in bipolar disorder.
A. Demjaha et al.
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Patients With First Onset Illness
While lateral ventricular enlargement is present at first
onset of schizophrenia, there is no convincing evidence
that this is the case for bipolar disorder. Gray matter ab-
normalities are also evident in first-episode schizophre-
nia. A meta-analysis of magnetic resonance imaging
studies conducted on first-episode patients with bipolar
disorder demonstrated that the total gray matter volume
appears to be unaffected at this stage.14
In summary, patients with established schizophrenia
and also bipolar disorder show generalized brain struc-
tural abnormalities, to a much greater extent in the for-
mer than in the latter. At first episode, patients with
schizophrenia but not those with bipolar disorder, al-
ready show some generalized abnormalities and decre-
ments in the hippocampus.
There remains debate about the causes of the abnor-
malities. Some factors appear to operate before the onset
of disorder; for example, hippocampal volume decrement
is particularly marked in those schizophrenic patients
who have been exposed to obstetric complications. How-
ever, further changes accumulate with length of illness.
Stress-related increases in cortisol, cannabis and alcohol
use, heavy smoking, and antipsychotics have all been pro-
posed to contribute to these changes.
Cognitive Profiles
Patients With Established Illness
Patients with established schizophrenia exhibit lower IQ,
memory and language impairment, and poor executive
functioning when compared with controls. Deficits are
also reported in those with established bipolar disorder
but these tend to be milder. Consequently, Krabbendam
et al15 showed that schizophrenia patients consistently
performed more poorly than bipolar patients.
Patients With First Episode of Illness
Cognitive deficits are present in first onset schizophrenia
while such deficits are either nonexistent or mild in first
episode of bipolar disorder. Zanelli et al16 confirmed that
those with schizophrenia demonstrated pervasive cogni-
tive deficits, while those with bipolar disorder showed
few; in particular, the schizophrenic patients showed pre-
morbid cognitive deficits, which were absent in bipolar
patients.
Prior to Illness Onset
Birth cohort studies consistently indicate that individuals
with schizophrenia have premorbid cognitive impair-
ments. These deficits appear absent or even reversed in
children who will later develop bipolar disorder. Cannon
and her colleagues17 reported that preschizophreniform
children showed deficits in cognitive function and neuro-
motor development but children who went on to develop
mania by 26 years performed significantly better than
controls on motor performance. A subsequent analysis
of data from the 32-year follow-up showed that higher
childhood IQ predicted risk of later mania.18
Both Israeli and Swedish cohorts have shown no differ-
ences in childhood cognition between premanics and con-
trols. Our group19 used the National Swedish registers to
examine school performance in adolescents who later de-
veloped schizophrenia and bipolar disorder. The poorer
the performance at school, the greater was the risk of
schizophrenia. In contrast, children with excellent school
performance showed increased risk of bipolar disorder.
Furthermore, these results persisted after adjusting for
socioeconomic group.
It is remarkable that high IQ and good school perfor-
mance predict bipolar disorder. One possibility is that the
genes, which increase susceptibility to mania, are also as-
sociated with good intellectual performance or even cre-
ativity. Another possibility is that certain genes predict
liability to a continuum of serious mental illness but
that those who are additionally neurodevelopmentally
compromised express schizophrenic symptoms, while
their cognitively unimpaired counterparts present a bipo-
lar picture.
The divergence in premorbid functioning also extends
to social functioning. While those destined to develop
schizophrenia show abnormalities in premorbid social
adjustment, Rietschel et al20 showed that 344 bipolar
patients had better childhood social adjustment than
137 healthy controls.
Dimensions and Development
Some have advocated the replacement of the Kraepeli-
nian diagnostic categories by symptom dimensions.
Our group has examined clinical correlates of such
dimensions in 2 different samples.21,22 In each of these
studies, factor analysis produced 5 factors (mania, reality
distortion, negative symptoms, depression, and disorga-
nization). In the first study,21 the strongest correlations
were between negative symptoms and poor premorbid
functioning and insidious onset and poor outcome; in
the second,22 the strongest association was between neg-
ative symptoms and soft neurological signs. In each case,
we interpreted the correlations as suggesting that nega-
tive symptoms index neurodevelopmentally compro-
mised individuals.
Conclusion
There exist both continuities and discontinuities between
schizophrenia and bipolar disorder. Any model that aims
to successfully represent psychosis needs to incorporate
both of these (figure 1). The evidence we have reviewed
suggests the following:
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The Effects of Illness
Following first diagnosis of either illness, individuals tend
to accumulate cognitive deficits and brain structural ab-
normalities, particularly if the illness is recurrent or
chronic; these deficits may be consequent upon illness
or associated factors such as substance misuse, a seden-
tary lifestyle and antipsychotics. Consequently, in com-
paring the etiology of the 2 illnesses, it is important to
concentrate on the picture at or before first onset of
the disorders rather than that which evolves thereafter.
Genes in Common
Genetic studies indicate that a number of risk alleles of
small effect predispose an individual to develop a func-
tional psychosis and that a number of these genes are
common to schizophrenia and bipolar disorder. This
overlap is presumably the reason why schizophrenia
and bipolar illness share certain pathophysiological sim-
ilarities, have overlapping symptoms and a similar age of
onset, and why symptoms of both illnesses benefit from
dopamine blockade.
Schizophrenia but Not Bipolar Disorder is Associated
With Neurodevelopmental Abnormality
At first onset of illness, many schizophrenia patients
show neuroanatomical changes and cognitive deficits,
which are absent in bipolar disorder. Diagnostic specific
genetic and environmental risk factors must determine
these differences. The excess of CNVs in schizophrenia
and the lack of such an excess in bipolar disorder further
supports our contention that the main difference between
the 2 conditions is the additional neurodevelopmental
component in schizophrenia. Such a view is consistent
with the evidence that a proportion of what is inherited
in schizophrenia is impaired intellect.
The impact of CNVs or risk alleles of genes involved
in neurodevelopment results in the subtle neuromotor,
cognitive, and behavioral impairment, which are seen in
many preschizophrenic children. Similar deviations
in neurodevelopment may occur following early envi-
ronmental insults, such as hypoxic damage to the hippo-
campus. Then when exposed to further environmental
stresses in adolescence or early adult life, there may
be hypothalamic-pituitary-adrenal overactivity and the re-
sultant raised cortisol induces further damage to the hip-
pocampus. Such a ‘‘second hit’’ to the developmentally
compromised hippocampus has been shown by Grace
and colleagues23 to lead to dopamine dysregulation in
their animal model of schizophrenia.
Two decades ago, we suggested that psychosis might be
profitably divided into those with and without neurode-
velopmental or congenital schizophrenia.24 More re-
cently, Kaymaz and Van Os2 have suggested that
‘‘psychotic disorders appear to be originating from over-
lapping areas of risk, one more developmental associated
with cognitive impairment and one more associated with
affective dysregulation’’. It is now clear that those who
Fig. 1. Diagram summarizing main differences and similarities between bipolar disorder and schizophrenia
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carry a major CNV or were exposed to severe hypoxia at
birth fall into the former category. They are likely to
show other indicators of neurodevelopmental impair-
ment as demonstrated by Leask et al25 who found that
indicators of neurodevelopmental risk were especially
common in schizophrenia without affective symptoms.
The model we have outlined suggests several areas for
further research. It is vital that the research effort in bi-
polar disorder is increased, particularly in areas where ev-
idence is rich for schizophrenia but is scanty or absent for
bipolar disorder. Further research is needed to clarify
how genetic and environmental risk factors alter the neu-
rodevelopmental trajectory of the individual, including
the study of gene-gene and gene-environment interac-
tions, and the epigenetic mechanisms by which environ-
ments may influence gene expression. The nature of the
neurodevelopmental impairment that predisposes to
schizophrenia, including its timing and its relationship
to cognitive function, also requires further research. Fi-
nally, the association between enhanced cognitive func-
tion and predisposition to bipolar disorder requires
explanation. Such research should improve our under-
standing of the etiology of both disorders and enable
us to refine our classification systems using models
that take etiological and biological factors into account.
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